Cempra Pharmaceuticals
Cempra Pharmaceuticals, Inc. discovers and develops well-differentiated medicines that cure infections
and improve quality of life for those with chronic illnesses. At the same time, the company strives to
meet urgent and continuing needs to treat drug-resistant bacteria in the hospital and community.
Learn More
News and Events
Cempra Pharmaceuticals Closes $46M Series C Financing
Funds will advance clinical development of two lead antibiotic compounds and the company's pre-clinical pipeline
New Study: CEM-101 is Active in vitro Against Six Clinically Significant Human Mycoplasma and Ureaplasma Species
Learn More
View All [+]